Published in Clin Interv Aging on December 02, 2013
The Relationship between Pulse Wave Velocity and Coronary Artery Stenosis and Percutaneous Coronary Intervention: a retrospective observational study. BMC Cardiovasc Disord (2017) 0.75
Ankle brachial index in coronary artery disease - author's reply. Clinics (Sao Paulo) (2014) 0.75
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 44.28
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med (2009) 17.17
Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA (2001) 13.65
Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA (2010) 8.90
Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med (2012) 8.39
Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation (2004) 7.30
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation (1993) 4.75
Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation (2012) 3.39
Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol (1999) 3.36
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2011) 2.71
Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial. Lancet (2011) 2.54
Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol (1996) 2.25
Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis (1997) 2.11
A modified calculation of ankle-brachial pressure index is far more sensitive in the detection of peripheral arterial disease. J Vasc Surg (2006) 1.73
Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol (1985) 1.71
Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. J Am Coll Cardiol (2011) 1.23
Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol (2000) 1.19
Ankle-brachial index as a predictor of coronary disease events in elderly patients submitted to coronary angiography. Clinics (Sao Paulo) (2013) 1.01
Peripheral arterial disease and progression of coronary atherosclerosis. J Am Coll Cardiol (2011) 1.00
Prevalence and prediction of previously unrecognized peripheral arterial disease in patients with coronary artery disease: the Peripheral Arterial Disease in Interventional Patients Study. Catheter Cardiovasc Interv (2009) 0.99
Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial. J Am Coll Cardiol (2010) 0.97
Usefulness of an abnormal ankle-brachial index for detecting multivessel coronary disease in patients with acute coronary syndrome. Rev Esp Cardiol (2010) 0.95
Mortality and morbidity in patients with intermittent claudication as defined by venous occlusion plethysmography. A ten-year follow-up study. J Chronic Dis (1981) 0.90
Population trends in percutaneous coronary intervention: 20-year results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry). J Am Coll Cardiol (2013) 0.89
The utility of carotid ultrasonography in identifying severe coronary artery disease in asymptomatic type 2 diabetic patients without history of coronary artery disease. Diabetes Care (2013) 0.89
Long-term health benefits and costs of measurement of carotid intima-media thickness in prevention of coronary heart disease. J Hypertens (2013) 0.86
[III Guidelines of Sociedade Brasileira de Cardiologia on the exercise test]. Arq Bras Cardiol (2010) 0.84
Prevalence and prognostic significance of asymptomatic peripheral arterial disease in 68-year-old men with diabetes. Results from the population study 'Men born in 1914' from Malmö, Sweden. Eur J Vasc Endovasc Surg (2005) 0.84
Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction. Arch Intern Med (2004) 0.84
A simplified lesion classification for predicting success and complications of coronary angioplasty. Registry Committee of the Society for Cardiac Angiography and Intervention. Am J Cardiol (2000) 0.84
A risk score for predicting peripheral arterial disease in individuals 75 years or older. Arq Bras Cardiol (2007) 0.78
Impact of carotid artery ultrasound and ankle-brachial index on prediction of severity of SYNTAX score. Circ J (2012) 0.78
A correlation study between ankle brachial pressure index and the severity of coronary artery disease. Int J Low Extrem Wounds (2012) 0.77
Ankle-brachial index and coronary artery lesion complexity in patients with acute coronary syndromes. Angiology (2012) 0.76
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation (2011) 6.36
In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol (2010) 2.85
Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation (2011) 2.18
Outcomes of patients with coronary artery perforation complicating percutaneous coronary intervention and correlations with the type of adjunctive antithrombotic therapy: pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials. J Interv Cardiol (2009) 1.64
SYNTAX score and the risk of stent thrombosis after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: an ACUITY trial substudy. Catheter Cardiovasc Interv (2014) 1.45
Impact of Chronic Total Occlusions on Revascularization Scores and Outcome Prediction. J Invasive Cardiol (2017) 1.40
Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. J Am Coll Cardiol (2011) 1.23
Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J Am Coll Cardiol (2009) 1.12
Organized thrombus mimicking spontaneous coronary artery dissection. JACC Cardiovasc Interv (2014) 1.07
[Hypertension prevalence and risk factors in a Brazilian urban population]. Arq Bras Cardiol (2010) 1.04
SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements. Circ Cardiovasc Interv (2011) 1.04
Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysis. J Am Coll Cardiol (2011) 1.01
Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. J Am Coll Cardiol (2012) 0.97
Incremental shuttle and six-minute walking tests in the assessment of functional capacity in chronic heart failure. Can J Cardiol (2008) 0.95
Predictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syndromes: the ACUITY Trial. Circ Cardiovasc Interv (2011) 0.86
Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study. JACC Cardiovasc Interv (2009) 0.86
Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial. EuroIntervention (2011) 0.86
Comparison of clinical and angiographic prognostic risk scores in patients with acute coronary syndromes: Analysis from the Acute Catheterization and Urgent Intervention Triage StrategY (ACUITY) trial. Am Heart J (2012) 0.83
Prediction of coronary risk by SYNTAX and derived scores: synergy between percutaneous coronary intervention with taxus and cardiac surgery. J Am Coll Cardiol (2013) 0.83
N-acetylcysteine in preventing contrast-induced nephropathy. To give, or not to give: that is the question. Rev Esp Cardiol (2010) 0.81
Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial). Am J Cardiol (2012) 0.80
Safety and efficacy of biolimus-eluting stent with biodegradable polymer: insights from EINSTEIN (Evaluation of Next-generation drug-eluting STEnt IN patients with coronary artery disease) Registry. Einstein (Sao Paulo) (2013) 0.80
A randomized trial comparing dual axis rotational versus conventional coronary angiography in a population with a high prevalence of coronary artery disease. J Interv Cardiol (2014) 0.80
Current status of the Xience V® everolimus-eluting coronary stent system. Expert Rev Cardiovasc Ther (2010) 0.80
Ischemia/reperfusion is an independent trigger for increasing myocardial content of mRNA B-type natriuretic peptide. Heart Vessels (2009) 0.79
[Different patterns for the 6-minute walk test as a test to measure exercise ability in elderly with and without clinically evident cardiopathy]. Arq Bras Cardiol (2006) 0.79
Role of probucol in inhibiting intimal hyperplasia after coronary stent implantation: a randomized study. Am Heart J (2006) 0.79
Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score. JACC Cardiovasc Interv (2013) 0.78
Prognostic value of serial brain natriuretic Peptide measurements in patients with acute myocardial infarction. Cardiology (2015) 0.78
Association among leukocyte count, mortality, and bleeding in patients with non-ST-segment elevation acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial). Am J Cardiol (2013) 0.78
Severity of the cardiac impairment determines whether digitalis prolongs or reduces survival of rats with heart failure due to myocardial infarction. Int J Cardiol (2012) 0.78
Very late stent thrombosis with bare-metal stent: identifying severe stent malapposition and underexpansion by intravascular ultrasound. Einstein (Sao Paulo) (2013) 0.78
A new score for risk stratification of patients with acute coronary syndromes undergoing percutaneous coronary intervention: the ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage Strategy-Percutaneous Coronary Intervention) risk score. JACC Cardiovasc Interv (2012) 0.77
Transcatheter bioprosthesis implantation for the treatment of aortic stenosis: three-year experience. Arq Bras Cardiol (2012) 0.77
[Guidelines for the indications of intracoronary ultrasonography in clinical practice]. Arq Bras Cardiol (2003) 0.77
Influence of gender on the risk of death and adverse events in patients with acute myocardial infarction undergoing pharmacoinvasive strategy. J Thromb Thrombolysis (2014) 0.77
Incidence, predictors, and impact of neurological events in non-ST-segment elevation acute coronary syndromes: the ACUITY trial. EuroIntervention (2015) 0.76
Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index. EuroIntervention (2015) 0.76
Saphenous vein graft thrombus findings by scanning electron microscopy in a patient with acute myocardial infarction. Einstein (Sao Paulo) (2013) 0.75
Restenosis and gene polymorphisms. All humans are equal, but some humans are more equal than others. Cardiology (2008) 0.75
Percutaneous left atrial appendage occlusion: putting the most lethal human attachment behind bars. Arq Bras Cardiol (2012) 0.75
Computed tomography angiography defined vulnerable plaque in a patient with low high-density lipoprotein cholesterol and subsequent myocardial infarction. Coron Artery Dis (2017) 0.75
The association between the extent of coronary artery disease and major bleeding events after percutaneous coronary intervention: from the ACUITY trial. J Invasive Cardiol (2015) 0.75
Assessing intermediate coronary lesions: angiographic prediction of lesion severity on intravascular ultrasound. J Invasive Cardiol (2007) 0.75
The SYNTAX Score Does Not Predict Risk of Adverse Events in Patients With Non-ST Elevation Acute Coronary Syndrome Who Undergo Coronary Artery Bypass Graft Surgery. J Invasive Cardiol (2016) 0.75